Engineering standards for trauma and orthopaedic implants worldwide : a systematic review protocol by Henshaw, Frederick et al.
1Henshaw F, et al. BMJ Open 2018;8:e021650. doi:10.1136/bmjopen-2018-021650
Open access 
Engineering standards for trauma and 
orthopaedic implants worldwide: a 
systematic review protocol
Frederick Henshaw,1 Eleni Karasouli,2 Richard King,1 Usama Rahman,1 
David Langton,2 June Madete,3 Fred Otsyeno,4 Vincent Mutiso,5 John Atinga,5 
Martin Underwood,1,2 Mark Williams,6 Andrew Metcalfe1,2
To cite: Henshaw F, Karasouli E, 
King R, et al.  Engineering 
standards for trauma and 
orthopaedic implants 
worldwide: a systematic 
review protocol. BMJ Open 
2018;8:e021650. doi:10.1136/
bmjopen-2018-021650
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
021650). 
Received 12 January 2018
Revised 23 June 2018
Accepted 12 July 2018
1Department of Orthopaedic 
surgery, University Hospitals 
Coventry and Warwickshire, 
Coventry, UK
2Warwick Clinical Trials Unit, 
University of Warwick, Coventry, 
UK
3Department of Electrical and 
Electronic Engineering, Kenyatta 
University, Nairobi, Kenya
4Department of Orthopaedic 
Surgery, Kenyatta National 
Hospital, Nairobi, Kenya
5Department of Orthopaedic 
Surgery, University of Nairobi, 
Nairobi, Kenya
6Warwick Manufacturing Group, 
University of Warwick, Coventry, 
UK
Correspondence to
Dr Frederick Henshaw;  
 freddie. henshaw@ btinternet. 
com
Protocol
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction Despite multiple scandals in the medical 
implant sector, premarket testing has been the attention 
of little published research. Complications related to new 
devices, such as the DePuy Articular Surface Replacement 
(ASR, DePuy Synthes, USA), have raised the issue of how 
designs are tested and whether engineering standards 
remain up to date with our understanding of implant 
biomechanics. Despite much work setting up national 
joint registries to improve implant monitoring, there have 
been few academic studies examining the premarket 
engineering standards new implants must meet. Emerging 
global economies mean that the markets have changed, 
and it is unknown to what degree engineering standards 
vary around the world. Governments, industry and 
independent regulatory bodies all produce engineering 
standards; therefore, the comparison of surgical implants 
across different manufacturers and jurisdictions is difficult. 
In this review, we will systematically collate and compare 
engineering standards for trauma and orthopaedic 
implants around the world. This will help inform patient, 
hospital and surgeon choice and provide an evidence base 
for future research in this area.
Methods and analysis This protocol is based on 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocol (PRISMA-P) guidelines. We will 
conduct a systematic review of trauma and orthopaedic 
engineering standards from four main sources of 
information as identified in our preliminary scoping 
searches: governments, industry, independent regulatory 
bodies and engineering and medical publications. Any 
current standard relevant to trauma and orthopaedic 
implants will be included. We will use a predefined search 
strategy and follow the recommendations of the Cochrane 
handbook where applicable. We will undertake a narrative 
synthesis with qualitative evaluation of homogeneity 
between engineering standards.
Ethics and dissemination No ethics approval is required 
as no primary data are being collected. The results will be 
made available by peer-reviewed publication and reported 
according to PRISMA-P guidelines.
IntroduCtIon  
Recent scandals in the field of medical 
implants1 2 have brought the sector under 
greater public and regulatory scrutiny, 
with questions about whether the current 
system is fit for purpose.3 Trauma and ortho-
paedic implants are classified among the 
riskiest devices by government regulators.4 
Over 11 000 revision operations for failed 
implants were required in the UK in 2016 
alone.5 Revision surgery is more costly than 
primary arthroplasty requiring longer opera-
tions, more postoperative investigations and 
lengthier hospital stays.6 Previous qualitative 
studies of implant regulation have described 
a reactive system that relies on postmarket 
surveillance of revision rates rather than 
rigorous premarket testing.4 7 This was 
demonstrated by the DePuy ASR resurfacing 
hip (DePuy Synthes, Raynham, Massachusetts, 
USA), a product that passed all premarket 
engineering standards before being discon-
tinued due to high revision rates.8 Despite 
this, there have been few scientific studies 
examining the breadth and suitability of engi-
neering standards that implants must meet 
before going to market.
Implant revision is costly for both the 
patient and the wider economy. In recent 
years, several countries have initiated joint 
strengths and limitations of this study
 ► Multidisciplinary team carrying out a systemat-
ic review from both a medical and engineering 
perspective.
 ► A team with experience in conducting systematic 
reviews and with the specific search methodology 
used in this review.
 ► Engineering standards may not be open to public 
scrutiny limiting our ability to carry out comprehen-
sive comparisons.
 ► For practical reasons, the study is limited to the 
G20 group of developed nations, the G23 groups of 
low-income and middle-income nations and the top 
10 trauma and orthopaedic manufacturers by mar-
ket value. This may lead to exclusion bias for less 
economically developed countries.
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registries to monitor implants and catch those with high 
revision rates early.7 These registries show large dispari-
ties in failure rates between different brands of implant. 
The UK National Joint Registry’s (NJR) worst performing 
total knee arthroplasty implant has a revision rate at 13 
years of 7.9% compared with 3.1% for the best.5 Such 
variability between brands is frequently put down to 
differences in design or materials2 5 9 and while the causes 
of implant failure are multifactorial, several key modes of 
failure are related to the quality of manufacturing of the 
implant. The medical literature does not reflect this; one 
systematic review found implant fracture rates in total hip 
arthroplasty as high as 16.3% yet no comment was made 
on the role of implant engineering standards.10 Similarly, 
interbrand differences are often put down to surgical 
technique or patient factors while the role of the manu-
facturing process is rarely mentioned.
Implants are increasingly being used in younger patient 
groups who place greater functional demands on their 
prostheses over a greater time period. As a result, they 
have substantially higher revision rates; for total hip 
arthroplasty, females aged under 55 have a revision rate 
of 13.5% compared with an average of 6.8% for the 
wider population.5 To cope with this increasing burden, 
implants need to be engineered and manufactured to 
the highest standard. The NJR found the incidence of 
implant fracture is greatest in the first year5 which suggests 
that implants manufactured to an insufficient standard 
are entering the market. While many publications offer 
evidence regarding the suitability of design or materials, 
there is little research to help surgeons, patients and 
purchasers discern the differences in the engineering 
quality of rival implants.
The topic of engineering standards is not widely 
explored in the medical literature, and this review aims to 
be the first to systematically address variability in trauma 
and orthopaedic engineering standards worldwide. Due 
to the paucity of information in traditional medical 
databases, we will adopt a cross-disciplinary approach 
searching both medical and engineering publications, 
as well as government and industry sources. We are not 
aware of any previous reviews describing and comparing 
the different engineering standards in use. A systematic 
review is required to aid policy-makers, purchasers and 
stakeholders in making informed decisions regarding the 
engineering quality of an implant.
objectives
To provide an overview of publicly available engineering 
standards for trauma and orthopaedic implants. To 
assess the homogeneity of engineering standards that are 
produced by different sources and applied in different juris-
dictions. To examine the public availability of the contents 
of trauma and orthopaedic engineering standards, specifi-
cally the tests that they specify and any pass/fail criteria that 
they set.
MEthods And AnAlysIs
This protocol will, where possible, conform to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
Protocol guidelines.11
Inclusion criteria
Our preliminary scoping review has shown engineering 
standards fall into three broad categories. First, general 
biocompatibility standards that all medical devices must 
meet, these will all be included. Second, material-specific 
standards, we will include: steel, titanium alloys, cobalt 
and chromium alloys, polyethylene, polyether ether 
ketone, zirconia and alumina ceramics. Third, standards 
specific to individual implant types, we will include: hip 
arthroplasty, knee arthroplasty, plates, nails, screws and 
wires. Due to the large number of different materials and 
implants in use and the expense of purchasing the associ-
ated engineering standards, our inclusion criteria will be 
limited to the most common materials and implant types 
as identified in our early scoping searches.5 12 13
For a standard to be included, it must come from one 
of the following sources: published scientific research 
paper, government of a G20 or G23 nation, organ-
isations appointed by a government of a G20 or G23 
nation to regulate trauma and orthopaedic implants, 
trauma and orthopaedic implant manufacturers, for 
example, Johnson & Johnson, Zimmer Biomet or 
industry standards body, for example, International 
Standards Organisation, British Standards Institute. 
Including both G20 developed nations, G23 low-in-
come and middle-income nations and international 
bodies associated with one or more members of the G20 
and G23 will capture a representative sample of govern-
ment produced or sanctioned engineering standards. 
It will also enable comparison between standards in 
developed and less economically developed countries. 
For the purposes of this study, the European Union will 
be treated as one state, and member nations will not be 
searched separately.
Engineering standards that are identified but do not 
come from these sources will be noted and discussed in 
the conclusion.
Exclusion criteria
We will exclude any engineering standard that has been 
repealed or superseded and engineering standards not 
available in the English language.
Population
The engineering standards for elective orthopaedics 
to be included are hip and knee implants. For trauma 
implants, any nail, plate, wire or screw will be considered.
Patient data are not being assessed in this review.
Intervention
Any published standard relevant to any process required 
for the manufacture of trauma and orthopaedic implants.
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outcome
The publication of engineering standards for trauma 
and orthopaedic implants is of primary interest. We will 
record the engineering standards name, origin, category 
and the device class it applies to.
Where engineering standards are publicly available, we 
will explore our secondary outcomes. We will investigate 
if they state any specific tests implants must undergo and 
where there are specific tests, we will investigate the exis-
tence of pass/fail criteria.
search strategy
The search strategy has been developed in consultation 
with librarians with experience of both engineering and 
healthcare journals. Our scoping searches have identified 
four sources of information on engineering standards for 
trauma and orthopaedic implants: governments or agen-
cies appointed by governments to regulate engineering 
standards on their behalf, international standards organ-
isations, trauma and orthopaedic implant manufacturers 
and published scientific papers. We will search medical 
and engineering online databases with the following 
search terms: ‘orthop*edic implant *’, ‘standard*’: and 
‘manufactur*’. We will search the following databases: 
Engineering Village, Scopus, Web of Science, Biotech-
nology Research Abstracts, Biotechnology and Bioen-
gineering abstracts, Ceramic abstracts, Medline (Ovid), 
Biological Sciences (Proquest), Cochrane library and 
Pubmed.
Government websites for all G20 and G23 nations will 
be searched for relevant standards databases or for the 
non-governmental organisations (NGOs) appointed to 
regulate trauma and orthopaedic engineering standards. 
In the case of NGOs being appointed, a further search 
of the NGO’s website will be carried out to identify rele-
vant engineering standards. The websites will be searched 
using the terms ‘medical device’ and ‘implant’. Where no 
engineering standards are identified, we will first email 
the government body or NGO responsible for producing 
standards. If this fails, we will approach appropriate 
academic staff at universities in the relevant country. We 
will ask them to contact the organisation responsible for 
producing engineering standards in that country and 
obtain the engineering standards on our behalf.
The G20 nations to be searched are: Argentina*, 
Australia, Brazil*, Canada, China*, European Union, 
India*,Indonesia*, Japan, Mexico*, Russia, Saudi Arabia, 
South Africa*, South Korea, Turkey and United States of 
America (*denotes nations who are also in the G23).
The G23 nations to be searched are: Bolivia, Chile, 
Cuba, Ecuador, Egypt, Guatemala, Nigeria, Pakistan, Para-
guay, Peru, Philippines, Tanzania, Thailand, Uruguay, 
Venezuela and Zimbabwe. Kenya will also be included in 
this list, as it is the nationality of several of our coauthors.
We will search the websites of international standards 
organisations and national standards organisations for 
G20 and G23 countries using the search terms ‘Medical 
Device’ and ‘Implant’.
The websites of the top 10 trauma and orthopaedic 
manufacturers by market capitalisation will be searched: 
currently, Johnson & Johnson, Zimmer Biomet, Stryker, 
Medtronic, Smith & Nephew, Arthrex, NuVasive, Globus 
Medical, Wright Medical Group and Tornier. The search 
terms used will be: ‘Engineering standard’ and ‘Device 
Standard’. Scoping reviews revealed limited search func-
tionality on some company websites. Therefore, we will 
also contact each company to ask which engineering stan-
dards they use for products marketed in our jurisdictions 
of interest.
Where engineering standards are not fully accessible 
via the above databases, the organisation responsible for 
publishing the standard will be contacted and a request 
made for the full standard. Results will be screened by FH 
and UR with those not relevant removed. Where there is 
a conflict about whether a document meets the inclusion 
or exclusion criteria, senior team members (EK, MW and 
AM) will arbitrate.
If there is consistent disagreement, the reviewing team 
will meet to re-evaluate the search criteria. Any changes 
to the methods described in this protocol will be clearly 
documented in the Methods section of the review.
study records
Search results from medical and engineering databases 
will be downloaded and managed in Mendeley. They will 
then be screened by using their title and abstract against 
the inclusion criteria. Studies emerged from this stage 
will then be judged against the inclusion criteria in their 
entirety. Documents yielded from websites or Google 
searches will only be downloaded if they meet inclusion 
criteria. Data extraction from the included articles will be 
carried out by FH and UR.
Patient and public involvement
There has been no direct patient or public involvement 
in the design of this study.
However, it is hoped that this study will inform public 
debate around the regulation of implant manufacturing, 
ultimately improving patient outcomes.
risk of bias
As the protocol is investigating engineering standards 
and not original research papers, a risk of bias assessment 
is not appropriate.
data synthesis and analysis
We will provide a narrative synthesis of our findings struc-
tured around the standard category (biocompatibility, 
material and implant specific) and origin (country, manu-
facturer, standards organisation). We will provide summa-
ries of the tests each country or region requires, if they 
are mandatory and any parameters that they set. We will 
then assess the homogeneity of engineering standards 
between different countries by comparing the number of 
shared engineering standards. Where multiple standards 
exist, we will assess consistency between specific test proto-
cols. This will most likely be qualitative but quantitative 
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summaries will be performed where appropriate. We 
will also assess whether pass/fail parameters are consis-
tent between standards using the same approach. Where 
testing processes are considered comparable between 
standards, we will present pass/fail parameters as box and 
whisker plots, range and, if appropriate, median IQR.
EthICs And dIssEMInAtIon
This study will not look at patient data and therefore does 
not require ethical approval.
The results will be disseminated through publication in 
a peer-reviewed journal.
dIsCussIon
Most research into why trauma and orthopaedic implants 
fail has focused on the design or material used in the 
implant. Little attention has been paid to differences 
in engineering quality between implants. This system-
atic review is needed to provide an overview of the engi-
neering standards currently in use and highlight areas for 
further research.
It is accepted that some of the standards in current 
use will be confidential standards applied by manufac-
turers. This is accepted as a weakness of the review, but 
equally such standards are not independently verifiable 
and cannot be externally audited. It is therefore still rele-
vant to ascertain what publicly available standards are 
in current use, as part of a package of work to improve 
the appropriateness and transparency of orthopaedic 
device standards in current use, for both established and 
emerging economies around the world.
Scoping searches prior to this review have found few 
publicly available engineering standards; this review will 
provide a systematic record of how many trauma and 
orthopaedic engineering standards are open to public 
scrutiny, the tests that they require and the variability in 
engineering standards between different countries.
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